We are live on !
Find out more
DPA
Devon Park Associates Portfolio holdings
AUM
$30.8M
Turnover
0%
1-Year Est. Return
0.85%
This Fund
S&P 500
This Quarter Est. Return
+27.42%
1 Year Est. Return
+0.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$30.8M
AUM Growth
+$6.62M
(+27%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.5
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$279M
| $30.8M | 100% |
810,927
| – | – |
2015 Q1
6 quarters
|
|
Similar funds
NCA
SIG
Devon Park Associates's Q3 2016 Portfolio in Review
As of Q3 2016, Devon Park Associates held 1 position worth $30.8M, up 27% from $24.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 0%. Devon Park Associates opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Devon Park Associates's ten largest holdings make up 100% of its $30.8M portfolio in Q3 2016.
- Devon Park Associates opened 0 new positions and closed 0 in Q3 2016.
- Devon Park Associates's portfolio value rose 27% quarter-over-quarter to $30.8M.
Based on Devon Park Associates's 13F filing for Q3 2016, filed 14 Nov 2016.